2007
DOI: 10.1097/bpo/0b013e3181558981
|View full text |Cite
|
Sign up to set email alerts
|

What Would Pediatric Infectious Disease Consultants Recommend for Management of Culture-Negative Acute Hematogenous Osteomyelitis?

Abstract: Level V.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
5
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(6 citation statements)
references
References 17 publications
1
5
0
Order By: Relevance
“…The 35.0% response rate for our own survey was lower than anticipated, but in view of the sensitive nature of the topic under investigation, it was not unexpected. Our response rate is still higher or comparable to similar studies using email as a distribution mode among physician specialists [ 31 , 32 ].…”
Section: Discussionsupporting
confidence: 83%
“…The 35.0% response rate for our own survey was lower than anticipated, but in view of the sensitive nature of the topic under investigation, it was not unexpected. Our response rate is still higher or comparable to similar studies using email as a distribution mode among physician specialists [ 31 , 32 ].…”
Section: Discussionsupporting
confidence: 83%
“…Given the distribution of pathogens in the different age groups, in neonates, empirical treatment should include oxacillin with the addition of gentamicin [ 18 , 19 ]. In children older than three months, to cover MSSA, S. pyogenes , and K. kingae , antistaphylococcal penicillin such as nafcillin or oxacillin or a first-generation cephalosporin such as cefazolin should be used [ 18 ]. However, in the case of a high suspicion of MRSA infection ( i.e.…”
Section: Controversies In Managementmentioning
confidence: 99%
“…Clindamycin has been proven to have high efficacy in bone infections [2,23]. Intravenous clindamycin can be used for treating critically ill children infected with MRSA with sequential shift from intravenous to oral administration [11,19].…”
Section: Discussionmentioning
confidence: 99%